Cofoe Medical Technology (301087.SZ) participates in the investment establishment of the Hangzhou Gongshu District Danlu Talent Intelligent Entrepreneurship Investment Fund.
Kang Fu Medical (301087.SZ) announced that the company has signed a "Partnership Agreement" with Guangzhou Dan Lu Equity Investment Management Co., Ltd. (hereinafter referred to as "Guangzhou Dan Lu"), Hangzhou Gaoke Technology Venture Investment Management Co., Ltd. (hereinafter referred to as "Hang Gao Investment"), Shenzhen Xin Hao Emerging Venture Investment Co., Ltd., Hangzhou Gongshu Industrial Fund Co., Ltd. (hereinafter referred to as "Gongshu Talent Entrepreneurship Fund"), and Sequoia Capital Yu Hui (Xiamen) Equity Investment Partnership Enterprise (Limited Partnership) to jointly invest in the establishment of the Hangzhou Gongshu District Dan Lu Talent Intelligent Entrepreneurship Investment Fund Partnership Enterprise (Limited Partnership) (hereinafter referred to as "Fund" or "Partnership Enterprise").
Cofoe Medical Technology (301087.SZ) announced that the company has signed a partnership agreement with Guangzhou Danlu Equity Investment Management Co., Ltd. (referred to as "Guangzhou Danlu"), Hangzhou Gaoke Technology Entrepreneurship Investment Management Co., Ltd. (referred to as "Hang Gaoke Investment"), Shenzhen Xinhao Emerging Entrepreneurship Investment Co., Ltd., Hangzhou Gongshu Industrial Fund Co., Ltd. (referred to as "Gongshu Talent Innovation Fund"), and Sequoia Yuhui (Xiamen) Equity Investment Partnership Enterprise (Limited Partnership) to jointly invest in the establishment of the Hangzhou Gongshu Danlu Talent Smart Entrepreneurship Investment Fund Partnership Enterprise (Limited Partnership) (referred to as "Fund" or "Partnership Enterprise").
All partners of the Fund have committed to a total subscription of 80 million Yuan, with the company using its own funds to subscribe for 20 million Yuan, representing a subscription ratio of 25.00%.
The investment direction of the Fund is consistent with the company's main business direction. The purpose of this investment is to ensure the stable development of the company's main business, fully utilize resources and investment management advantages from all parties, enhance the company's investment income level and capital operation capabilities, expand the company's industrial layout, and promote the company's sustainable development.
Related Articles
.png)
The wave of software sell-offs has affected the private equity giants in the US, and top executives are coming forward to appease investors.

META SPACEX (01796) plans to offer a discount of approximately 2.6% to issue 16.7 million subscription shares, raising approximately HK$50 million net.

ALMANA(08186) announces 2025 performance net profit of 1.69 million Hong Kong dollars, a year-on-year increase of approximately 7.94 times.
The wave of software sell-offs has affected the private equity giants in the US, and top executives are coming forward to appease investors.
.png)
META SPACEX (01796) plans to offer a discount of approximately 2.6% to issue 16.7 million subscription shares, raising approximately HK$50 million net.

ALMANA(08186) announces 2025 performance net profit of 1.69 million Hong Kong dollars, a year-on-year increase of approximately 7.94 times.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


